Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schwartz

Showing results (51-60 of 1,626) with videos related to

Pageof 163
Sort By:
Cancer Causes & Control : CCC|March 20, 2002
Hypothesis: does ochratoxin A cause testicular cancer?Gary G Schwartz
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1994
Correspondence re: E. H. Corder et al., Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol., Biomarkers & Prev., 2: 467-472, 1993G G Schwartz
Annals of Epidemiology|July 16, 2008
Vitamin D and intervention trials in prostate cancer: from theory to therapyGary G Schwartz
Future Oncology (London, England)|June 13, 2009
Is serum calcium a biomarker of fatal prostate cancer?Gary G Schwartz
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1997
Multiple myeloma: clusters, clues, and dioxinsG G Schwartz
Cancer Research|October 1, 1973
The protective effect of estradiol-17 beta against polycyclic hydrocarbon cytotoxicityA G Schwartz
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 22, 2010
Early insights of cardiac risk and treatment response with quantitative PET monitoring of coronary-specific endothelial dysfunction and myocardial perfusion reserveRonald G Schwartz
The American Journal of Medicine|June 24, 2010
Metoclopramide and digoxin cause 22 episodes of bradyarrhythmiasBryan G Schwartz
The Journal of Urology|February 22, 2011
Approaches to optimizing vitamin D therapy in prostate cancerGary G Schwartz
Journal of the American College of Cardiology|February 25, 2017
Who Should Receive Ezetimibe?Gregory G Schwartz
Pageof 163

Showing results (51-60 of 1,626) with videos related to

Sort By:
Pageof 163
Cancer Causes & Control : CCC|March 20, 2002
Hypothesis: does ochratoxin A cause testicular cancer?Gary G Schwartz
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1994
Correspondence re: E. H. Corder et al., Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol., Biomarkers & Prev., 2: 467-472, 1993G G Schwartz
Annals of Epidemiology|July 16, 2008
Vitamin D and intervention trials in prostate cancer: from theory to therapyGary G Schwartz
Future Oncology (London, England)|June 13, 2009
Is serum calcium a biomarker of fatal prostate cancer?Gary G Schwartz
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1997
Multiple myeloma: clusters, clues, and dioxinsG G Schwartz
Cancer Research|October 1, 1973
The protective effect of estradiol-17 beta against polycyclic hydrocarbon cytotoxicityA G Schwartz
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 22, 2010
Early insights of cardiac risk and treatment response with quantitative PET monitoring of coronary-specific endothelial dysfunction and myocardial perfusion reserveRonald G Schwartz
The American Journal of Medicine|June 24, 2010
Metoclopramide and digoxin cause 22 episodes of bradyarrhythmiasBryan G Schwartz
The Journal of Urology|February 22, 2011
Approaches to optimizing vitamin D therapy in prostate cancerGary G Schwartz
Journal of the American College of Cardiology|February 25, 2017
Who Should Receive Ezetimibe?Gregory G Schwartz
Pageof 163